PHAXIAM Therapeutics S.A.
PHXM
Rang în acțiuni
#39374
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Preț acțiune
$0.11725176
Ultima sincronizare: 2025-07-14
Capitalizare de piață
$481.50K
Schimbare (1 zi)
-0.20%
Schimbare (1 an)
3.89%
Țară
FR
Tranzacționează PHAXIAM Therapeutics S.A. (PHXM)
Categorie
Healthcare
Istoric al prețului acțiunii pentru PHAXIAM Therapeutics S.A. (PHXM)
Cel mai mare preț de închidere: $0.11 pe 2025-09-01
Cel mai mic preț de închidere: $244.88 pe 2014-09-01
Cel mai mic preț de închidere: $244.88 pe 2014-09-01
Istoric al prețului acțiunii pentru PHAXIAM Therapeutics S.A. din 2014 până în 2026
Evoluția anuală a prețului acțiunii
| An | Performanță |
|---|---|
| 2025 | -93.86% |
| 2024 | -59.46% |
| 2023 | -33.86% |
| 2022 | -70.66% |
| 2021 | -72.34% |
| 2020 | 46.24% |
| 2019 | -20.11% |
| 2018 | -66.93% |
| 2017 | 58.80% |
| 2016 | -58.92% |
| 2015 | 3.13% |
| 2014 | 0.00% |
Prețul acțiunii pentru companii similare sau concurente
| Companie | Preț acțiune | Variație 1an% | Țara |
|---|---|---|---|
| $536.98 | 25.92% |
US
|
|
| $224.77 | 737.11% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $876.75 | 7.69% |
NL
|
